Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Int J Mol Sci ; 24(3)2023 Feb 03.
Article in English | MEDLINE | ID: mdl-36769304

ABSTRACT

As it is well known, messenger RNA has many regulatory regions along its sequence length. One of them is the 5' untranslated region (5'UTR), which itself contains many regulatory elements such as upstream ORFs (uORFs), internal ribosome entry sites (IRESs), microRNA binding sites, and structural components involved in the regulation of mRNA stability, pre-mRNA splicing, and translation initiation. Activation of the alternative, more upstream transcription start site leads to an extension of 5'UTR. One of the consequences of 5'UTRs extension may be head-to-head gene overlap. This review describes elements in 5'UTR of protein-coding transcripts and the functional significance of protein-coding genes 5' overlap with implications for transcription, translation, and disease.


Subject(s)
Gene Expression Regulation , Protein Biosynthesis , 5' Untranslated Regions , RNA, Messenger/genetics , Regulatory Sequences, Nucleic Acid
2.
Int J Mol Sci ; 22(6)2021 Mar 21.
Article in English | MEDLINE | ID: mdl-33801123

ABSTRACT

CRISPR/Cas (clustered regularly interspaced short palindromic repeats linked to Cas nuclease) technology has revolutionized many aspects of genetic engineering research. Thanks to it, it became possible to study the functions and mechanisms of biology with greater precision, as well as to obtain genetically modified organisms, both prokaryotic and eukaryotic. The changes introduced by the CRISPR/Cas system are based on the repair paths of the single or double strand DNA breaks that cause insertions, deletions, or precise integrations of donor DNA. These changes are crucial for many fields of science, one of which is the use of animals (pigs) as a reservoir of tissues and organs for xenotransplantation into humans. Non-genetically modified animals cannot be used to save human life and health due to acute immunological reactions resulting from the phylogenetic distance of these two species. This review is intended to collect and summarize the advantages as well as achievements of the CRISPR/Cas system in pig-to-human xenotransplantation research. In addition, it demonstrates barriers and limitations that require careful evaluation before attempting to experiment with this technology.


Subject(s)
CRISPR-Cas Systems , Gene Editing , Genetic Engineering , Organ Transplantation , Transplantation, Heterologous , Animals , DNA Breaks, Double-Stranded , DNA Repair , Graft Rejection , Graft Survival , Heterografts , Humans , Models, Animal , Organ Transplantation/adverse effects , Organ Transplantation/methods , Swine
3.
Genes (Basel) ; 11(6)2020 06 26.
Article in English | MEDLINE | ID: mdl-32604937

ABSTRACT

The increasing life expectancy of humans has led to an increase in the number of patients with chronic diseases and organ failure. However, the imbalance between the supply and the demand for human organs is a serious problem in modern transplantology. One of many solutions to overcome this problem is the use of xenotransplantation. The domestic pig (Sus scrofa domestica) is currently considered as the most suitable for human organ procurement. However, there are discrepancies between pigs and humans that lead to the creation of immunological barriers preventing the direct xenograft. The introduction of appropriate modifications to the pig genome to prevent xenograft rejection is crucial in xenotransplantation studies. In this study, porcine GGTA1, CMAH, ß4GalNT2, vWF, ASGR1 genes were selected to introduce genetic modifications. The evaluation of three selected gRNAs within each gene was obtained, which enabled the selection of the best site for efficient introduction of changes. Modifications were examined after nucleofection of porcine primary kidney fibroblasts with CRISPR/Cas9 system genetic constructs, followed by the tracking of indels by decomposition (TIDE) analysis. In addition, off-target analysis was carried out for selected best gRNAs using the TIDE tool, which is new in the research conducted so far and shows the utility of this tool in these studies.


Subject(s)
CRISPR-Cas Systems/genetics , Genetic Vectors/genetics , Swine/genetics , Transplantation, Heterologous , Animals , Animals, Genetically Modified/genetics , Asialoglycoprotein Receptor/genetics , Galactosyltransferases/genetics , Gene Knockout Techniques , Heterografts , Humans , Mixed Function Oxygenases/genetics , Mutation/genetics , von Willebrand Factor/genetics
4.
Genes (Basel) ; 11(6)2020 06 19.
Article in English | MEDLINE | ID: mdl-32575461

ABSTRACT

Progress in genetic engineering over the past few decades has made it possible to develop methods that have led to the production of transgenic animals. The development of transgenesis has created new directions in research and possibilities for its practical application. Generating transgenic animal species is not only aimed towards accelerating traditional breeding programs and improving animal health and the quality of animal products for consumption but can also be used in biomedicine. Animal studies are conducted to develop models used in gene function and regulation research and the genetic determinants of certain human diseases. Another direction of research, described in this review, focuses on the use of transgenic animals as a source of high-quality biopharmaceuticals, such as recombinant proteins. The further aspect discussed is the use of genetically modified animals as a source of cells, tissues, and organs for transplantation into human recipients, i.e., xenotransplantation. Numerous studies have shown that the pig (Sus scrofa domestica) is the most suitable species both as a research model for human diseases and as an optimal organ donor for xenotransplantation. Short pregnancy, short generation interval, and high litter size make the production of transgenic pigs less time-consuming in comparison with other livestock species This review describes genetically modified pigs used for biomedical research and the future challenges and perspectives for the use of the swine animal models.


Subject(s)
Animals, Genetically Modified/genetics , Biomedical Research/trends , Genetic Engineering , Swine/genetics , Animals , Gene Transfer Techniques , Heterografts , Humans , Models, Animal , Tissue Donors , Transplantation, Heterologous/methods
SELECTION OF CITATIONS
SEARCH DETAIL